More Details on This News

Jubilant Generics Limited, a step-down wholly owned subsidiary of Jubilant Pharmova Limited, has made an initial investment of CAD 30,000 (approximately ₹0.20 crore) in Jubilant Pharmaceuticals Inc., Canada. This investment, which occurred on December 30, 2025, establishes Jubilant Pharmaceuticals Inc. as a step-down wholly owned subsidiary of Jubilant Pharmova.

The acquired entity, Jubilant Pharmaceuticals Inc., incorporated on June 17, 2025, in Canada, is in the Pharmaceuticals Industry. Its stated objective is to establish a branded generic business in Canada, thereby strengthening Jubilant's presence in the Canadian market and driving revenue growth. The entity has not yet commenced business operations and thus has no turnover for the last three years. The acquisition was completed through an initial cash investment of CAD 30,000 to subscribe to 30,000 shares of common stock, resulting in 100% shareholding by Jubilant Generics Limited.

No specific governmental or regulatory approvals were required for this acquisition. The Promoter and Promoter group have no interest in the acquired entity beyond their shareholding in the holding company, Jubilant Pharmova Limited, and the transaction is considered an arm's length transaction.